Comparison between Goldline Pharmaceutical IPO and K.V.Toys India IPO.
Goldline Pharmaceutical IPO is a SME Bookbuilding IPO proposed to list at BSE SME while K.V.Toys India IPO is a SME Bookbuilding proposed to list at BSE SME.
| Goldline Pharmaceutical IPO | K.V.Toys India IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Cumulative Capital Pvt.Ltd. | GYR Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Purva Sharegistry (India) Pvt.Ltd. |
| Market Maker | Nirman Share Brokers Pvt.Ltd. | Giriraj Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Goldline Pharmaceutical IPO is up to ₹11.02 Cr whereas the issue size of the K.V.Toys India IPO is up to ₹37.74 Cr. The final issue price of Goldline Pharmaceutical IPO is ₹43.00 per share and of K.V.Toys India IPO is ₹239.00 per share.
| Goldline Pharmaceutical IPO | K.V.Toys India IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹41.00 per share | ₹227.00 per share |
| Issue Price (Upper) | ₹43.00 per share | ₹239.00 per share |
| Issue Price (Final) | ₹43.00 per share | ₹239.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 600 shares |
| Fresh Issue Size | 25,62,000 shares | 15,79,200 shares |
| Fresh Issue Size (Amount) | up to ₹11.02 Cr | up to ₹37.74 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 25,62,000 shares | 15,79,200 shares |
| Issue Size Total (Amount) | up to ₹11.02 Cr | up to ₹37.74 Cr |
Goldline Pharmaceutical IPO opens on May 12, 2026, while K.V.Toys India IPO opens on Dec 08, 2025. The closing date of Goldline Pharmaceutical IPO and K.V.Toys India IPO is May 14, 2026, and Dec 10, 2025, respectively.
| Goldline Pharmaceutical IPO | K.V.Toys India IPO | |
|---|---|---|
| Anchor Bid Date | May 11, 2026 | Dec 05, 2025 |
| Issue Open | May 12, 2026 | Dec 08, 2025 |
| Issue Close | May 14, 2026 | Dec 10, 2025 |
| Basis Of Allotment (Tentative) | May 15, 2026 | Dec 11, 2025 |
| Initiation of Refunds (Tentative) | May 18, 2026 | Dec 12, 2025 |
| Credit of Share (Tentative) | May 18, 2026 | Dec 12, 2025 |
| Listing date (Tentative) | May 19, 2026 | Dec 15, 2025 |
| Anchor Lockin End date 1 | Jun 14, 2026 | Jan 12, 2026 |
| Anchor Lockin End date 2 | Aug 13, 2026 | Mar 13, 2026 |
Goldline Pharmaceutical IPO P/E ratio is 10.47, as compared to K.V.Toys India IPO P/E ratio of 23.94.
| Goldline Pharmaceutical IPO | K.V.Toys India IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 79.70 | 79.65 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 57.29 | 58.35 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 10.47 | 23.94 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹41.28 Cr. | ₹150.09 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 35.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 38.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.50 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.11 | ₹9.98 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 27.37 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Goldline Pharmaceutical IPO Retail Individual Investors (RII) are offered 9,00,000 shares while in K.V.Toys India IPO retail investors are offered 9,00,000 shares. Qualified Institutional Buyers (QIB) are offered 5,40,000 shares in Goldline Pharmaceutical IPO and 3,12,600 shares in K.V.Toys India IPO.
| Goldline Pharmaceutical IPO | K.V.Toys India IPO | |
|---|---|---|
| Anchor Investor Reservation | 7,32,000 shares | 4,68,000 shares |
| Market Maker Reservation | 1,38,000 shares | 1,00,800 shares |
| QIB | 5,40,000 shares | 3,12,600 shares |
| NII | 3,90,000 shares | 2,39,400 shares |
| RII | 9,00,000 shares | 5,59,200 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 25,62,000 shares | 15,79,200 shares |
Goldline Pharmaceutical IPO subscribed 600.53x in total, whereas K.V.Toys India IPO subscribed 248.12x.
| Goldline Pharmaceutical IPO | K.V.Toys India IPO | |
|---|---|---|
| QIB (times) | 180.22x | 193.25x |
| NII (times) | 1,662.04x | 505.19x |
| Big NII (times) | 2,010.60x | 577.76x |
| Small NII (times) | 980.75x | 360.05x |
| RII (times) | 881.15x | 376.41x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 600.53x | 248.12x |
